moxalactam has been researched along with cilastatin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Takada, M | 1 |
| Kumagai, K; Nishibuchi, M; Otsuki, H; Takeda, Y | 1 |
| Bustamante, CI; Drusano, GL; Forrest, A; Leslie, J; Moody, M; Rivera, G; Standiford, HC; Tatem, B | 1 |
| Berkeley, AS; Freedman, KS; Hirsch, JC; Ledger, WJ | 1 |
| Calandra, GB; Grad, C; Hesney, M | 1 |
4 trial(s) available for moxalactam and cilastatin
| Article | Year |
|---|---|
A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
Topics: Adult; Aged; Bacterial Infections; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Lung Neoplasms; Male; Middle Aged; Moxalactam; Multivariate Analysis; Neutropenia; Random Allocation; Tobramycin; Treatment Outcome | 1991 |
Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers.
Topics: Adolescent; Adult; Bacteria; Cilastatin; Cyclopropanes; Humans; Imipenem; Injections, Intravenous; Kinetics; Male; Moxalactam; Protein Binding; Thienamycins | 1986 |
Randomized, comparative trial of imipenem/cilastatin and moxalactam in the treatment of serious obstetric and gynecologic infections.
Topics: Acute Disease; Adolescent; Adult; Cesarean Section; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Dipeptidases; Drug Administration Schedule; Drug Therapy, Combination; Endometritis; Female; Humans; Imipenem; Moxalactam; Pelvic Inflammatory Disease; Pregnancy; Pregnancy Complications, Infectious; Random Allocation; Thienamycins | 1986 |
A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Tolerance; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Thienamycins | 1984 |
3 other study(ies) available for moxalactam and cilastatin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
[An in vitro study on combination effect of isepamicin and beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens | 1990 |